ACADEMISCH MEDISCH CENTRUM
26Patents
23Active
26Granted
50Portfolio score
Filing activity: Sep 1, 2004 → Jul 14, 2020 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9131861B2 | Pulsed lighting imaging systems and methods | Human Necessities | 56 | Expired |
| US9623055B2 | Method for preventing and/or treating insulin resistance | Human Necessities | 20 | Active |
| US9433650B2 | Method for preventing and/or treating insulin resistance | Human Necessities | 20 | Active |
| US8750952B2 | Apparatus and method for dating a body sample | Physics | 14 | Active |
| US10907951B2 | Single-chip optical coherence tomography device | Physics | 9 | Active |
| US9029161B2 | Apparatus and method for dating a body or body sample | Physics | 8 | Active |
| US7296479B2 | Force sensor and laparoscopic instrument provided with such a force sensor | Human Necessities | 4 | Expired |
| US8529885B2 | AAV vectors for in vivo gene therapy of rheumatoid arthritis | Human Necessities | 3 | Expired |
| US10280218B2 | Antibodies binding to BMP4, and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10195337B2 | System for flushing a pericardial cavity | Human Necessities | 1 | Active |
| US10974041B2 | Neuromodulation device | Human Necessities | 1 | Active |
| US10753724B2 | Common-path integrated low coherence interferometry system and method therefor | Physics | 0 | Active |
| US11650212B2 | Screening method for cerebrotendinous xanthomatosis using bile alcohol glucuronides and metabolite ratios | Physics | 0 | Active |
| US8410081B2 | Treatment of cystic fibrosis | Human Necessities | 0 | Active |
| US11648287B2 | Composition for the treatment of intracellular bacterial infection | Emerging Cross-Sectional Technologies | 0 | Active |
| US10435463B2 | Hepatitis C virus specific antibody | Chemistry; Metallurgy | 0 | Active |
| US10914634B2 | High-resolution integrated-optics-based spectrometer | Physics | 0 | Active |
| US11103504B2 | Combination of a DNA condensation-inducing compound and an Eis inhibitor for antibiotic treatment | Human Necessities | 0 | Active |
| US11344618B2 | HIV envelope glycoprotein immunogens | Chemistry; Metallurgy | 0 | Active |
| US11504243B2 | Device and method for determination of the moment-induced movement of a joint implant | Human Necessities | 0 | Active |
| US10189784B2 | N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitors of glucosylceramide synthase | Chemistry; Metallurgy | 0 | Active |
| US10130677B2 | Antimicrobial peptide and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US10456439B2 | NK3 agonist for use in the treatment of a patient suffering from atrial arrhythmia or fibrillation | Human Necessities | 0 | Active |
| US11534465B2 | Fecal matter for treatment of autoimmune diseases | Human Necessities | 0 | Active |
| US11067381B2 | Common-path integrated low coherence interferometry system and method therefor | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.